Genprex Capital Surpluse from 2010 to 2025

GNPX Stock  USD 0.38  0.01  2.70%   
Genprex Capital Surpluse yearly trend continues to be fairly stable with very little volatility. Capital Surpluse is likely to outpace its year average in 2025. During the period from 2010 to 2025, Genprex Capital Surpluse regression line of annual values had r-squared of  0.86 and arithmetic mean of  46,618,169. View All Fundamentals
 
Capital Surpluse  
First Reported
2017-09-30
Previous Quarter
130.5 M
Current Value
132 M
Quarterly Volatility
41.1 M
 
Covid
Check Genprex financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genprex's main balance sheet or income statement drivers, such as Depreciation And Amortization of 17 K, Interest Expense of 21.9 M or Selling General Administrative of 9.2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.85. Genprex financial statements analysis is a perfect complement when working with Genprex Valuation or Volatility modules.
  
Check out the analysis of Genprex Correlation against competitors.
For more information on how to buy Genprex Stock please use our How to Invest in Genprex guide.

Latest Genprex's Capital Surpluse Growth Pattern

Below is the plot of the Capital Surpluse of Genprex over the last few years. It is Genprex's Capital Surpluse historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Genprex's overall financial position and show how it may be relating to other accounts over time.
Capital Surpluse10 Years Trend
Slightly volatile
   Capital Surpluse   
       Timeline  

Genprex Capital Surpluse Regression Statistics

Arithmetic Mean46,618,169
Geometric Mean29,961,161
Coefficient Of Variation85.62
Mean Deviation35,998,471
Median38,690,590
Standard Deviation39,915,202
Sample Variance1593.2T
Range97.4M
R-Value0.93
Mean Square Error237.3T
R-Squared0.86
Slope7,779,255
Total Sum of Squares23898.4T

Genprex Capital Surpluse History

2025107.8 M
2024102.7 M
202089.3 M
201943.5 M
201838.7 M
201717.9 M
201615.8 M

About Genprex Financial Statements

Genprex investors use historical fundamental indicators, such as Genprex's Capital Surpluse, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Genprex. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capital Surpluse102.7 M107.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Genprex Stock Analysis

When running Genprex's price analysis, check to measure Genprex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genprex is operating at the current time. Most of Genprex's value examination focuses on studying past and present price action to predict the probability of Genprex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genprex's price. Additionally, you may evaluate how the addition of Genprex to your portfolios can decrease your overall portfolio volatility.